Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

MYELOPROLIFERATIVE DISORDERS

Finding the right KIT inhibitor for advanced systemic mastocytosis

Two early-phase clinical trials show impressive response rates and symptom improvement with the selective KIT inhibitor avapritinib, which will provide a much-needed new treatment option for patients.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: SM symptoms, mediators and organ impact of indolent and advanced disease.

References

  1. Valent, P., Akin, C. & Metcalfe, D. D. Blood 129, 1420–1427 (2017).

    Article  CAS  Google Scholar 

  2. Metcalfe, D. D. J. Invest. Dermatol. 96, 2S–4S (1991).

    Article  Google Scholar 

  3. Castells, M. & Austen, K. F. Int. Arch. Allergy Immunol. 127, 147–152 (2002).

    Article  CAS  Google Scholar 

  4. Theoharides, T. C., Valent, P. & Akin, C. N. Engl. J. Med. 373, 163–172 (2015).

    Article  CAS  Google Scholar 

  5. Escribano, L., Akin, C., Castells, M., Orfao, A. & Metcalfe, D. D. Ann. Hematol. 81, 677–690 (2002).

    Article  CAS  Google Scholar 

  6. Escribano, L. et al. J. Allergy Clin. Immunol. 124, 514–521 (2009).

    Article  Google Scholar 

  7. Lim, K. H. et al. Blood 113, 5727–5736 (2009).

    Article  CAS  Google Scholar 

  8. Nagata, H. et al. Proc. Natl Acad. Sci. USA 92, 10560–10564 (1995).

    Article  CAS  Google Scholar 

  9. DeAngelo, D. J. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01538-9 (2021).

  10. Gotlib, J. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01539-8 (2021).

  11. Gotlib, J. et al. N. Engl. J. Med. 374, 2530–2541 (2016).

    Article  CAS  Google Scholar 

  12. Castells, M. & Butterfield, J. J. Allergy Clin. Immunol. Pract. 7, 1097–1106 (2019).

    Article  Google Scholar 

  13. Akin et al. J. Allergy Clin. Immunol. 145, AB336 (2020).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariana Castells.

Ethics declarations

Competing interests

M.C. and C.A. have consultancy agreement with and receive research funding from Blueprint Medicines.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Castells, M., Akin, C. Finding the right KIT inhibitor for advanced systemic mastocytosis. Nat Med 27, 2081–2082 (2021). https://doi.org/10.1038/s41591-021-01588-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-021-01588-z

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer